Oncternal Therapeutics Announces Formation of Cell Therapy Scientific Advisory Board

November 2, 2021 sandiegobiotech News Comments Off on Oncternal Therapeutics Announces Formation of Cell Therapy Scientific Advisory Board

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the establishment of its Cell Therapy Scientific Advisory Board (SAB). The Cell Therapy SAB is comprised of industry and academic leaders in the cell therapy field, covering important areas of expertise including cutting edge research, preclinical development, manufacturing, and clinical development.

Click here to view original post

Related Articles

No Picture
News

Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

November 1, 2021 sandiegobiotech News Comments Off on Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it has granted an inducement award to one new employee, Mohab Hassanin, who joined the Company as Clinical Trial Manager. Click here to view original post… […]

No Picture
News

Oncternal Therapeutics to Participate in September Investor Conferences

September 10, 2021 sandiegobiotech News Comments Off on Oncternal Therapeutics to Participate in September Investor Conferences

SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that management will participate in the following conferences in the month of September: Click here to view original post… […]

No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results

July 29, 2021 sandiegobiotech News Comments Off on Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2021 financial results after the U.S. financial markets close on Thursday, August 5, 2021. Oncternal’s management will host a… Click here to view original post… […]